RW
Robert W Weber
Chief Financial Officer

Robert W Weber insider trades: Hollis Eden Pharmaceuticals (HEPH) stock sales

Chief Financial Officer, Hollis Eden Pharmaceuticals Last trade Mar 5, 2007 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2005
1
Company
last trade 2007

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 5, 2007HEPH↓ Sell$16K
Feb 5, 2007HEPH↓ Sell$16K
Jan 8, 2007HEPH↓ Sell$16K
Aug 21, 2006HEPH↓ Sell$5K
Mar 13, 2006HEPH↓ Sell$114K
Sep 12, 2005HEPH↓ Sell$18K
Aug 12, 2005HEPH↓ Sell$15K
Jul 21, 2005HEPH↓ Sell$13K
May 16, 2005HEPH↓ Sell$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert W Weber's insider trades

Robert W Weber is Chief Financial Officer at Hollis Eden Pharmaceuticals (HEPH). Since May 16, 2005, Robert has reported no open-market purchases and 9 sales worth $224K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (9 filings), grants and awards (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HEPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.